Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.8-<2
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
0.1-<0.3
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
42.3
EC/CAS
18641-57-1
Name of the chemical
glycerol tribehenate
Concentration
16.4
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
3.3
EC/CAS
9050-36-6
Name of the chemical
Maltodextrin
Concentration
1.6
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
31-<34
General Information
Revision date
2020-05-20
Product name
REQUIP-MODUTAB PROLONGED RELEASE TABLETS
Product Synonyms
REQUIP LP * REQUIP XL * REQUIP DEPOT * REQUIP-MODUTAB * REQUIP PROLONGED
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Not classified. OSHA defined hazards Not classified.
Hazard pictograms
None.
Signal word
None.
Hazard statements
Not available.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
24.685% of the mixture consists of component(s) of unknown acute oral toxicity. 85.935% of the mixture consists of component(s) of unknown acute dermal toxicity. 80.135% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 80.135% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
